Disclosure Quest - Search SEC Filings

Name	Type of Offering	Accepted Date
Entero Therapeutics, Inc. See All Filings	D	2025-08-18 10:40:07 UTC
Amount To Be Raised $3,025,000 Associated Brokers / Dealers N/A CIK Number 0001604191 Filed Document 0001104659-25-079619 Exclusions or Exemptions 506b Accepted Date 2025-08-18 10:40:07 UTC Type of Offering D Industry Biotechnology Principal Place of Business FLORIDA Revenue or Assets Decline to Disclose Type of Security Option To Acquire
First Wave BioPharma, Inc. See All Filings	D	2023-09-21 16:12:35 UTC
Amount To Be Raised $1,470,509 Associated Brokers / Dealers Roth Capital Partners, LLC CIK Number 0001604191 Filed Document 0001104659-23-102819 Exclusions or Exemptions 506b Accepted Date 2023-09-21 16:12:35 UTC Type of Offering D Industry Biotechnology Principal Place of Business FLORIDA Revenue or Assets Decline to Disclose Type of Security Option To Acquire
First Wave BioPharma, Inc. See All Filings	D	2023-06-28 16:05:20 UTC
Amount To Be Raised $431,083 Associated Brokers / Dealers Roth Capital Partners, LLC CIK Number 0001604191 Filed Document 0001104659-23-075792 Exclusions or Exemptions 506b Accepted Date 2023-06-28 16:05:20 UTC Type of Offering D Industry Biotechnology Principal Place of Business FLORIDA Revenue or Assets Decline to Disclose Type of Security Option To Acquire
First Wave BioPharma, Inc. See All Filings	D	2023-03-23 17:00:04 UTC
Amount To Be Raised $4,000,001 Associated Brokers / Dealers Roth Capital Partners, LLC CIK Number 0001604191 Filed Document 0001104659-23-036120 Exclusions or Exemptions 506b Accepted Date 2023-03-23 17:00:04 UTC Type of Offering D Industry Biotechnology Principal Place of Business FLORIDA Revenue or Assets Decline to Disclose Type of Security Equity
First Wave BioPharma, Inc. See All Filings	D	2022-12-01 16:12:59 UTC
Amount To Be Raised $2,500,001 Associated Brokers / Dealers H.C. Wainwright & Co. LLC CIK Number 0001604191 Filed Document 0001104659-22-123662 Exclusions or Exemptions 506b Accepted Date 2022-12-01 16:12:59 UTC Type of Offering D Industry Biotechnology Principal Place of Business FLORIDA Revenue or Assets Decline to Disclose Type of Security Equity
First Wave BioPharma, Inc. See All Filings	D	2022-07-26 17:00:48 UTC
Amount To Be Raised $300,000 Associated Brokers / Dealers H.C. Wainwright & Co. LLC CIK Number 0001604191 Filed Document 0001104659-22-082821 Exclusions or Exemptions 506b Accepted Date 2022-07-26 17:00:48 UTC Type of Offering D Industry Biotechnology Principal Place of Business FLORIDA Revenue or Assets Decline to Disclose Type of Security Equity
AzurRx BioPharma, Inc. See All Filings	D	2020-07-31 12:26:01 UTC
Amount To Be Raised $22,800,000 Associated Brokers / Dealers Alexander Capital, L.P. CIK Number 0001604191 Filed Document 0000905718-20-000795 Exclusions or Exemptions 506b Accepted Date 2020-07-31 12:26:01 UTC Type of Offering D Industry Biotechnology Principal Place of Business NEW YORK Revenue or Assets Decline to Disclose Type of Security Equity
AzurRx BioPharma, Inc. See All Filings	D	2020-01-17 16:56:07 UTC
Amount To Be Raised $8,000,000 Associated Brokers / Dealers Alexander Capital, L. P. CIK Number 0001604191 Filed Document 0001415889-20-000125 Exclusions or Exemptions 506b Accepted Date 2020-01-17 16:56:07 UTC Type of Offering D Industry Biotechnology Principal Place of Business NEW YORK Revenue or Assets $No Revenues Type of Security Debt
AzurRx BioPharma, Inc. See All Filings	D	2019-02-28 18:22:24 UTC
Amount To Be Raised $2,000,000 Associated Brokers / Dealers N/A CIK Number 0001604191 Filed Document 0001415889-19-000233 Exclusions or Exemptions 506b Accepted Date 2019-02-28 18:22:24 UTC Type of Offering D Industry Biotechnology Principal Place of Business NEW YORK Revenue or Assets $No Revenues Type of Security Debt
AzurRx BioPharma, Inc. See All Filings	D	2017-06-15 13:14:40 UTC
Amount To Be Raised $5,000,000 Associated Brokers / Dealers Alexander Capital, LP CIK Number 0001604191 Filed Document 0001415889-17-001001 Exclusions or Exemptions 506b Accepted Date 2017-06-15 13:14:40 UTC Type of Offering D Industry Biotechnology Principal Place of Business NEW YORK Revenue or Assets Decline to Disclose Type of Security Equity
AzurRx BioPharma, Inc. See All Filings	D	2017-04-21 12:38:42 UTC
Amount To Be Raised $1,000,000 Associated Brokers / Dealers N/A CIK Number 0001604191 Filed Document 0001415889-17-000663 Exclusions or Exemptions 506b Accepted Date 2017-04-21 12:38:42 UTC Type of Offering D Industry Biotechnology Principal Place of Business NEW YORK Revenue or Assets $No Revenues Type of Security Debt
AzurRx BioPharma, Inc. See All Filings	D	2016-04-11 00:00:00 UTC
Amount To Be Raised $12,000,000 Associated Brokers / Dealers Alexander Capital, LP CIK Number 0001604191 Filed Document 0001415889-16-005478 Exclusions or Exemptions 506b Accepted Date 2016-04-11 00:00:00 UTC Type of Offering D Industry Biotechnology Principal Place of Business NEW YORK Revenue or Assets Decline to Disclose Type of Security Debt
AzurRx BioPharma, Inc. See All Filings	D	2014-11-03 00:00:00 UTC
Amount To Be Raised $7,000,000 Associated Brokers / Dealers Alexander Capital, LP CIK Number 0001604191 Filed Document 0001415889-14-003295 Exclusions or Exemptions 506b Accepted Date 2014-11-03 00:00:00 UTC Type of Offering D Industry Biotechnology Principal Place of Business NEW YORK Revenue or Assets Decline to Disclose Type of Security Debt
BioPharma d'Azur, Inc. See All Filings	D	2014-04-02 00:00:00 UTC
Amount To Be Raised $1,020,250 Associated Brokers / Dealers N/A CIK Number 0001604191 Filed Document 0001144204-14-020145 Exclusions or Exemptions 506b Accepted Date 2014-04-02 00:00:00 UTC Type of Offering D Industry Biotechnology Principal Place of Business NEW YORK Revenue or Assets Decline to Disclose Type of Security Equity